US tariffs on China to lend a hand to Malaysia’s glove makers
The tariffs are expected to revitalise investor sentiment and reclaim market share, with analysts predicting a return to profitability for the sector
Top Glove jumped as much as 32 per cent, the most ever, while Hartalega Holdings Bhd rallied by the 30 per cent limit. The gains come a day after Thailand peers spiked, as analysts point out that Southeast Asian producers will be the main beneficiaries. Malaysia’s market was closed for a holiday on Monday.
US tariffs on Chinese medical gloves will rise to 50 per cent in 2025 and 100 per cent in 2026, Citi analysts wrote in a report. That’s up from a 25 per cent hike proposed in May, which was to take effect in 2026.
The impending levy provides yet another fillip for Southeast Asian equities, which are already bolstered by growing bets the region will be a beneficiary from a Federal Reserve interest-rate pivot. Four of the five best-performing Asian stock benchmarks this month are from the region, with inflows in September poised for the highest level since April 2022.